Antiviral therapy, HBsAg seroclearance and late recurrence of Hepatitis B-related hepatocellular carcinoma. Liu SY, Yuan C, Tong XM. J Hepatol 2022 Jul 18. pii: S0168-8278(22)02938.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu SY, Yuan C, Tong XM. Antiviral therapy, HBsAg seroclearance and late recurrence of Hepatitis B-related hepatocellular carcinoma. J Hepatol 2022 Jul 18. pii: S0168-8278(22)02938.
PMID: 35863489